Hepatocellular Carcinoma by BCLC Stage
7 clinical trials · Condition
◉ Watch Hepatocellular Carcinoma by BCLC Stage
| Record | Firm | Date |
|---|---|---|
| A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET) (NCT05214339) | Sun Yat-sen University | 2022-03-16 |
| Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma (NCT03652896) | Huazhong University of Science and Technology | 2019-01-01 |
| Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization (NCT04780789) | Brno University Hospital | 2015-02-01 |
| Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer (NCT03515252) | Ivy Life Sciences, Co., Ltd | 2005-04-26 |
Track Hepatocellular Carcinoma by BCLC Stage automatically
Every clearance here is in the API, with alerts when new ones post.